Unituxin Injection
Product Images NDC 66302-014

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Unituxin (NDC 66302-014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by United Therapeutics Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Unituxin 01)

A Kaplan-Meier survival curve chart depicting event-free survival probability over years since randomization. The chart compares two groups: one treated with Unituxin plus RA and the other with RA alone, showing higher survival probability for the Unituxin/RA group. Numbers of subjects at risk are displayed below the x-axis for each time point up to 7 years.*

FDA Label Image

Principal Display Panel (5 mL Single Use Vial Box)

Unituxin (dinutuximab) Injection 17.5 mg/5 mL (3.5 mg/mL) single-dose vial carton label. The label states the product is for intravenous infusion only and must be diluted prior to administration. It contains no preservative and lists manufacturer United Therapeutics Corporation. Storage instructions note refrigeration at 2-8°C and protection from light. The label includes NDC 66302-014-01 and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.